Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Genzyme

Status: Completed

Conditions: Bone Marrow / Autologous Transplants

Treatments: Drug: Plerixafor

Study type: Observational

Funder types: Industry

Identifiers

NCT01738373

MOZ22510

Details and patient eligibility

About

The aim of this registry is to provide information, in day-to-day practice, on Plerixafor prescription modalities in France, over a 13-month period in order to address the health authorities' request.

Enrollment: 262 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients treated with Plerixafor for autologous transplantation between November 2011 and November 2012
• Patients who have been informed and who have given their written consent for the access to their medical file

Exclusion criteria

• Patients already included in a Plerixafor ongoing clinical trial.